Cytori Therapeutics, Inc. (NASDAQ: CYTX) will host a live webcast to discuss the two year follow-up results from the SCLERADEC I trial for scleroderma. There will also be time allocated for Q&A. The academic presentation of the trial findings is scheduled for Saturday, February 20, 2016 at the 4th Systemic Sclerosis World Congress in Lisbon, Portugal, and will be presented by trial co-principal investigator Dr. Guy Magalon.

The dial-in information for the Monday, February 22, 8:30 AM Eastern time call is as follows:

Dial-In Number: +1 (877) 402-3914
Conference ID: 56735683

The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of the company’s investor relations website.

Cytori Fourth Quarter Financial Results and Update

Webcast scheduled for Thursday, March 3rd, 2016 at 5:30 PM ET

In addition, Cytori will host a live webcast of its fourth quarter and fiscal year 2015 financial results and business update on Thursday, March 3, 2016 at 5:30 PM Eastern Time.

The dial-in information is as follows:

Dial-In Number: +1 (877) 402-3914
Conference ID: 32453785

Prior to the webcast at approximately 4:30 PM Eastern Time on March 3, Cytori will issue its fourth quarter earnings release, which will review Cytori’s fourth quarter and fiscal year 2015 performance. The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of Cytori’s investor relations website.

About Cytori Therapeutics, Inc.

Cytori Therapeutics is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy™ may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori’s proprietary technologies and products. For more information: visit www.cytori.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160219005943/en/